In a joint statement on April 8, the American Heart Association, the American College of Cardiology, and the Heart Rhythm Society cast doubts as to the safety of hydroxychloroquine and azithromycin for potential prophylaxis or treatment for COVID-19; both drugs are listed as definite causes of torsade de pointes” and increase in the risk of other arrhythmias and sudden death”, the statement says. In addition “seriously ill patients often have comorbidities that can increase risk of serious arrhythmias,” including hypokalemia, hypomagnesemia, fever, and systemic inflammation, the groups said.
Link to PDF:
Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment